Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Oragenics Inc
OGEN | US
0.96
USD0.06
6.70%
OGEN | US
Loading StockChartView...
About Oragenics Inc
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
09/03/2026
Close
0.96
Open
0.88
High
0.98
Low
0.88
Oragenics Inc. a development-stage company engages in the research and development of antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1 an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus. The company's product candidates also comprise LPT3-04 a weight loss candidate; and SMaRT Replacement Therapy a topical treatment to prevent dental carries. It has a license agreement with Noachis Terra Inc. for licensing of certain specified patent rights and biological materials relating to the use of pre-fusion coronavirus spike proteins; and a collaboration agreement ILH Holdings Inc. for the development and commercialization of MU1140 and related homologs. The company was formerly known as Oragen Inc. Oragenics Inc. was incorporated in 1996 and is headquartered in Tampa Florida.
View LessOGEN | US
Risk
98.1
Sharpe
-0.84
Luna's Score
39/100
Recommendation
Sell
Luna says (OGEN | US)
What's Working
Low Market Beta (-0.4 to 0.8)
What's not Working
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
94.6%1 month
98.1%3 months
88.2%6 months
77.2%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
7.57
Debt to equity
-
Debt to assets
-
Ent. to EBITDA
0.21
Ent. to rev.
105.83
PEG
-
Other Fundamentals
EBITDA
-19.64M
MarketCap
10.12M
MarketCap(USD)
10.12M
Div. yield
-
Op. margin
-263.29K
Erngs. growth
-
Rev. growth
-91.30
Ret. on equity
-454.72
Short ratio
0.25
Short perc.
1.45
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
0.38
Range1M
0.40
Range3M
0.42
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.63
Price X volume
267.48K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 0.21 | 0.53 | Cheaper |
| Ent. to Revenue | 105.83 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 7.57 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 88.17 | 72.80 | Riskier |
| Debt to Equity | - | -1.23 | - |
| Debt to Assets | - | 0.25 | - |
| Market Cap | 10.12M | 3.66B | Emerging |
